These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2417351)

  • 1. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
    Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW
    Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
    Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR
    Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
    Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
    Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
    [No Abstract]   [Full Text] [Related]  

  • 4. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis.
    Von Bonsdorff M; Stiekema J; Harjanne A; Alapiessa U
    Int J Artif Organs; 1990 Feb; 13(2):103-8. PubMed ID: 2347652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
    Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
    Frei U; Wilks MF; Boehmer S; Crisp-Lindgren N; Schwarzrock R; Stiekema JC; Koch KM
    Nephrol Dial Transplant; 1988; 3(4):435-9. PubMed ID: 2459635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
    Biller J; Massey EW; Marler JR; Adams HP; Davis JN; Bruno A; Henriksen RA; Linhardt RJ; Goldstein LB; Alberts M
    Neurology; 1989 Feb; 39(2 Pt 1):262-5. PubMed ID: 2464774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications.
    Henny CP; Ten Cate H; Ten Cate JW; Surachno S; van Bronswijk H; Wilmink JM; Ockelford PA
    Lancet; 1983 Apr; 1(8330):890-3. PubMed ID: 6132219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
    Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
    Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
    J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
    Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
    Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of heparin fractions, fragments, and heparinoids.
    Messmore HL
    Semin Thromb Hemost; 1985 Apr; 11(2):208-12. PubMed ID: 2412297
    [No Abstract]   [Full Text] [Related]  

  • 14. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
    Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
    Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Dabhoiwala NF
    Thromb Haemost; 1987 Feb; 57(1):92-6. PubMed ID: 2438799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Magnani HN; Hull RD; Gent M
    Lancet; 1987 Mar; 1(8532):523-6. PubMed ID: 2434815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
    de Boer A; Kluft C; Dooijewaard G; Kasper FJ; Kroon JM; Breimer DD; Stiekema JC; Cohen AF
    Thromb Haemost; 1992 Nov; 68(5):550-5. PubMed ID: 1280862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
    de Boer A; Danhof M; Cohen AF; Magnani HN; Breimer DD
    Thromb Haemost; 1991 Aug; 66(2):202-7. PubMed ID: 1722918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.
    Stiekema JC; Wijnand HP; Van Dinther TG; Moelker HC; Dawes J; Vinchenzo A; Toeberich H
    Br J Clin Pharmacol; 1989 Jan; 27(1):39-48. PubMed ID: 2468354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activity of a new heparinoid.
    Ockelford PA; Carter CJ; Hirsh J
    Pathology; 1985 Jan; 17(1):78-81. PubMed ID: 4000717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.